Discover 764 paid clinical trials in Sacramento, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 764
Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
for
Open Angle Glaucoma (OAG)
Location: Sacramento CA, Petaluma CA, Glendale AZ,
Sponsor: Avisi Technologies Inc.
Sex: All
Age: 45+
Code: NCT07220876
Recruiting
Fidgeting and Attentional and Emotional Regulation in ADHD
for
ADHD
Location: Sacramento CA
Sponsor: University of California, Davis
Sex: All
Age: 18 - 30
Code: NCT04526600
Recruiting
Shaping Tolerance for Delayed Rewards
for
Impulsivity
Location: Sacramento CA
Sponsor: University of California, Davis
Sex: All
Age: 3 - 6
Code: NCT03457402
Recruiting
Virtual Reality Attention Management
for
ADHD
Location: Sacramento CA
Sponsor: University of California, Davis
Sex: All
Age: 8 - 12
Code: NCT03221244
Recruiting
Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)
for
Fragile X Syndrome
Location: Sacramento CA, Orange CA, Irvine CA, Phoenix AZ,
Sponsor: Mirum Pharmaceuticals, Inc.
Sex: Male
Age: 13 - 45
Code: NCT07209462
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Examining the Effectiveness of the Early Start Denver Model in Community Programs Serving Young Autism
for
Autism
Location: Sacramento CA
Sponsor: University of California, Davis
Sex: All
Age: 1+
Code: NCT06005285
Recruiting
Pilot Study Exploring the Effects of Rhythmic Auditory Stimulation on Gait in People With Motor Incomplete Spinal Cord Injury
for
Spinal Cord Injury
Location: Sacramento CA
Sponsor: University of California, Davis
Sex: All
Age: 18+
Code: NCT07674927
Recruiting
Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions
for
Spinal Fusion
Location: Sacramento CA, Redwood City CA, Calgary, Minneapolis MN,
Sponsor: AO Foundation, AO Spine
Sex: All
Age: 45+
Code: NCT06368245
Recruiting
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration